Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Semaglutide Tablet

Approval Number

国药准字SJ20240006

CompanyNovo Nordisk A/S

Registration Date

April 9, 2024

Drug Information

Generic Name

司美格鲁肽片

Trade Name

诺和忻

Dosage Form

片剂

Strength

14mg

Drug Type

生物制品

Registration Date

April 9, 2024

Expiry Date

January 22, 2029

Company Information

Applicant Company

Company NameNovo Nordisk A/S

Company Address

Novo Alle, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

Company NameNovo Nordisk A/S

Company Address

Novo Nordisk Park, 2760 Maaloev, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy